Clinical trial

Haptoglobin Phenotype and Cardiovascular Complications in Diabetic Patients

NCT00448487 · Dr. Shany Blum, Other · Completed

Key facts

NCT number NCT00448487
Title Haptoglobin Phenotype and Cardiovascular Complications in Diabetic Patients
Official title Prospective Observational Study to Asses the Incidence of CVD Complications in Diabetic Patients Pre-stratified by Haptoglobin Phenotype From the I CARE Registry
Acronym ICARER
Lead sponsor Dr. Shany Blum, Other
Collaborators Clalit Health Services
Status Completed
Study type Observational
Conditions Diabetes, Cardiovascular Disease, Myocardial Infarction
Enrollment 3,054
Start date Apr 1, 2005
Primary completion Jun 1, 2008
Completion Jun 1, 2008
First posted Mar 16, 2007
Last update posted Jun 12, 2015
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies